SetPoint Medical launches first-in-human MS pilot study using implanted nerve stimulation device

Eton Pharmaceuticals relaunches HEMANGEOL with new distribution model

The company says the product will now be distributed exclusively through Anovo Specialty Pharmacy

India unveils first-ever national framework to tackle childhood diabetes

New policy aims to standardise screening, diagnosis and lifelong care for children with diabetes across India’s public health system

Kapil Dev inaugurates Digital PET-CT and Nuclear Medicine Department at Mahajan Imaging & Labs

New facility at Pusa Road expands advanced diagnostic, theranostics, and treatment-planning capabilities across oncology, cardiology, neurology, and nephrology

FDA advisory panel backs AstraZeneca prostate cancer combo in decisive vote

The Committee backed the combination based on results from the CAPItello-281 Phase III trial, marking a key milestone in the regulatory pathway for AstraZeneca’s targeted therapy strategy in prostate cancer

FDA advisory panel narrowly withholds support for AstraZeneca’s combo in breast cancer

The FDA’s Oncologic Drugs Advisory Committee (ODAC) voted 3 to 6 against recommending camizestrant in combination with a CDK4/6 inhibitor

Merck posts mixed Q1 2026 results as blockbuster drugs drive growth

But acquisition charges drag earnings into loss

PFCD panel flags insurance gaps limiting access to robotic joint replacement in India

Leading orthopaedic experts call for equitable insurance coverage to patients for accessing advanced, precision-driven joint replacement technologies

Inside India’s qPCR Transformation: Scale, Shift, and Structural Change

Reshaped by COVID-19, rising test demand, and a shift toward decentralized diagnostics, qPCR has evolved from niche academic use to a core clinical engine

India's healthcare policymakers call for digital health expansion and system strengthening

Two-day long National Health Summit highlighted progress under the NHM and called for data-driven and SDG-aligned health system reforms